Concepedia

Yumi Cleary

YC

Statistics

Publications

13

Citations

365

H-Index

11

Active since

2015

Affiliations

Roche (Switzerland)(Current)

Roche (United Kingdom)

Institut de Myologie

Roche (United States)

Fondazione IRCCS Istituto Neurologico Carlo Besta

Yumi Cleary is an author at Roche (Switzerland) specializing in medicine, pharmacotherapy, and pharmacology.

ORCID

Top concepts

Publications per year

2015–2023

13

Publications

13

A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a <i>SMN2</i> splicing modifier

Stefan Sturm, Andreas Guenther, Birgit Jaber et al. · British Journal of Clinical Pharmacology · 2018 · 98 citations · Full text

Clinical Drug–Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib

Peter N. Morcos, Yumi Cleary, Elena Guerini et al. · Clinical Pharmacology in Drug Development · 2016 · 46 citations

, , +16

Model‐Based Drug–Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular Atrophy

Yumi Cleary, Michael Gertz, Paul Grimsey et al. · Clinical Pharmacology & Therapeutics · 2021 · 45 citations · Full text

Model‐Based Assessments of CYP‐Mediated Drug–Drug Interaction Risk of Alectinib: Physiologically Based Pharmacokinetic Modeling Supported Clinical Development

Yumi Cleary, Michael Gertz, Peter N. Morcos et al. · Clinical Pharmacology & Therapeutics · 2017 · 29 citations

Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathway

Sheng Feng, Yumi Cleary, Neil Parrott et al. · European Journal of Clinical Pharmacology · 2015 · 26 citations

, , +11

Rows per page

1–5 of 13